Astec LifeSciences Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 1,171.81 million compared to INR 1,733.53 million a year ago. Revenue was INR 1,209.7 million compared to INR 1,753.13 million a year ago. Net income was INR 8.4 million compared to INR 247.47 million a year ago. Basic earnings per share from continuing operations was INR 0.43 compared to INR 12.63 a year ago. Diluted earnings per share from continuing operations was INR 0.43 compared to INR 12.62 a year ago.
For the nine months, sales was INR 5,011.94 million compared to INR 4,045.84 million a year ago. Revenue was INR 5,116.79 million compared to INR 4,082.47 million a year ago. Net income was INR 305.48 million compared to INR 468.04 million a year ago. Basic earnings per share from continuing operations was INR 15.58 compared to INR 23.89 a year ago. Diluted earnings per share from continuing operations was INR 15.58 compared to INR 23.88 a year ago.